Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-16-741740
Filing Date
2016-10-19
Accepted
2016-10-19 16:06:04
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d254545d424b5.htm 424B5 869471
2 GRAPHIC g254545g41v22.jpg GRAPHIC 34197
3 GRAPHIC g254545g43l76.jpg GRAPHIC 23699
4 GRAPHIC g254545g63y17.jpg GRAPHIC 24668
5 GRAPHIC g254545g64k53.jpg GRAPHIC 25954
  Complete submission text file 0001193125-16-741740.txt   1020267
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-211511 | Film No.: 161942658
SIC: 2834 Pharmaceutical Preparations